ArticleESMO open2019

Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project.

Amanda Katherina Herbrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.